{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:44:42Z","timestamp":1783007082903,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/sc.2016.3","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T16:42:41Z","timestamp":1455640961000},"page":"494-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and safety of phosphodieterase-5 inhibitors for treatment of erectile dysfunction secondary to spinal cord injury: a systemic review and meta-analysis"],"prefix":"10.1038","volume":"54","author":[{"given":"D-D","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-B","family":"Shuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-M","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"issue":"Suppl 2","key":"BFsc20163_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0090-4295(02)01690-4","volume":"60","author":"F Derry","year":"2002","unstructured":"Derry F, Hultling C, Seftel AD, Sipski ML . Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review. Urology 2002; 60 (Suppl 2): 49\u201357.","journal-title":"Urology"},{"key":"BFsc20163_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10790268.2001.11753553","volume":"24","author":"WH Gans","year":"2001","unstructured":"Gans WH, Zaslau S, Wheeler S, Galea G, Vapnek JM . Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med 2001; 24: 35\u201340.","journal-title":"J Spinal Cord Med"},{"key":"BFsc20163_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1464-410X.2004.04565.x","volume":"93","author":"RT Strebel","year":"2004","unstructured":"Strebel RT, Reitz A, Tenti G, Curt A, Hauri D, Schurch B . Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury. BJU Int 2004; 93: 100\u2013104.","journal-title":"BJU Int"},{"key":"BFsc20163_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1743-6109.2011.02615.x","volume":"9","author":"G Lombardi","year":"2012","unstructured":"Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G . Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med 2012; 9: 970\u2013985.","journal-title":"J Sex Med"},{"key":"BFsc20163_CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0094-0143(21)00513-9","volume":"20","author":"SE Althof","year":"1993","unstructured":"Althof SE, Levine SB . Clinical approach to the sexuality of patients with spinal cord injury. Urol Clin North Am 1993; 20: 527\u2013534.","journal-title":"Urol Clin North Am"},{"key":"BFsc20163_CR6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","volume":"338","author":"I Goldstein","year":"1998","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397\u20131404.","journal-title":"N Engl J Med"},{"key":"BFsc20163_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0090-4295(02)01606-0","volume":"59","author":"SE Althof","year":"2002","unstructured":"Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803\u2013810.","journal-title":"Urology"},{"key":"BFsc20163_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/apmr.2002.33654","volume":"83","author":"TL Fisher","year":"2002","unstructured":"Fisher TL, Laud PW, Byfield MG, Brown TT, Hayat MJ, Fiedler IG . Sexual health after spinal cord injury: a longitudinal study. Arch Phys Med Rehabil 2002; 83: 1043\u20131051.","journal-title":"Arch Phys Med Rehabil"},{"key":"BFsc20163_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3928\/0279-3695-19880401-12","volume":"26","author":"L Pervin-Dixon","year":"1988","unstructured":"Pervin-Dixon L . Sexuality and the spinal cord injured. J Psychosoc Nurs Mental Health Serv 1988; 26: 31\u201334.","journal-title":"J Psychosoc Nurs Mental Health Serv"},{"key":"BFsc20163_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/01.psy.0000133969.80612.71","volume":"66","author":"CC Carson","year":"2004","unstructured":"Carson CC . Erectile dysfunction: evaluation and new treatment options. Psychosom Med 2004; 66: 664\u2013671.","journal-title":"Psychosom Med"},{"key":"BFsc20163_CR11","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/jsm.12047","volume":"10","author":"A Hamidi Madani","year":"2013","unstructured":"Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S . Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus. J Sex Med 2013; 10: 1146\u20131150.","journal-title":"J Sex Med"},{"key":"BFsc20163_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.030419997","volume":"97","author":"P Hedlund","year":"2000","unstructured":"Hedlund P, Aszodi A, Pfeifer A, Alm P, Hofmann F, Ahmad M et al. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc Natl Acad Sci USA 2000; 97: 2349\u20132354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsc20163_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1095\/biolreprod52.3.485","volume":"52","author":"AL Burnett","year":"1995","unstructured":"Burnett AL . Role of nitric oxide in the physiology of erection. Biol Reprod 1995; 52: 485\u2013489.","journal-title":"Biol Reprod"},{"key":"BFsc20163_CR14","first-page":"47","volume":"8","author":"M Boolell","year":"1996","unstructured":"Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47\u201352.","journal-title":"Int J Impot Res"},{"key":"BFsc20163_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000343730","volume":"90","author":"L Yang","year":"2013","unstructured":"Yang L, Qian S, Liu L, Pu C, Yuan H, Han P et al. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis. Urol Int 2013; 90: 339\u2013347.","journal-title":"Urol Int"},{"key":"BFsc20163_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/jsm.12068","volume":"10","author":"AL Martin","year":"2013","unstructured":"Martin AL, Huelin R, Wilson D, Foster TS, Mould JF . A systematic review assessing the economic impact of sildenafil citrate (Viagra) in the treatment of erectile dysfunction. J Sex Med 2013; 10: 1389\u20131400.","journal-title":"J Sex Med"},{"key":"BFsc20163_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.18553\/jmcp.2005.11.2.151","volume":"11","author":"HE Campbell","year":"2005","unstructured":"Campbell HE . Clinical monograph for drug formulary review: erectile dysfunction agents. J Manag Care Pharm 2005; 11: 151\u2013171.","journal-title":"J Manag Care Pharm"},{"key":"BFsc20163_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/aja.2011.70","volume":"14","author":"M Fode","year":"2012","unstructured":"Fode M, Krogh-Jespersen S, Brackett NL, Ohl DA, Lynne CM, Sonksen J . Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl 2012; 14: 61\u201368.","journal-title":"Asian J Androl"},{"key":"BFsc20163_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.sc.3101210","volume":"39","author":"A Sanchez Ramos","year":"2001","unstructured":"Sanchez Ramos A, Vidal J, Jauregui ML, Barrera M, Recio C, Giner M et al. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2001; 39: 637\u2013643.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/j.1442-2042.2006.01584.x","volume":"13","author":"Y Kimoto","year":"2006","unstructured":"Kimoto Y, Sakamoto S, Fujikawa K, Tachibana T, Yamamoto N, Otani T . Up-titration of vardena fi l dose from 10\u2009mg to 20\u2009mg improved erectile function in men with spinal cord injury. Int J Urol 2006; 13: 1428\u20131433.","journal-title":"Int J Urol"},{"key":"BFsc20163_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.sc.3101617","volume":"42","author":"G Del Popolo","year":"2004","unstructured":"Del Popolo G, Li Marzi V, Mondaini N, Lombardi G . Time\/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord 2004; 42: 643\u2013648.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR22","unstructured":"Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 &#91; updated March 2011&#93. The Cochrane Collaboration 2011. Available at http:\/\/handbook.cochrane.org\/ ."},{"key":"BFsc20163_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557\u2013560.","journal-title":"BMJ"},{"key":"BFsc20163_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2605.2009.01033.x","volume":"33","author":"MH Khorrami","year":"2010","unstructured":"Khorrami MH, Javid A, Moshtaghi D, Nourimahdavi K, Mortazavi A, Zia HR . Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries. Int J Androl 2010; 33: 861\u2013864.","journal-title":"Int J Androl"},{"key":"BFsc20163_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.sc.3100803","volume":"37","author":"MC Maytom","year":"1999","unstructured":"Maytom MC, Derry FA, Dinsmore WW, Glass CA, Smith MD, Orr M et al. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999; 37: 110\u2013116.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U","volume":"46","author":"F Giuliano","year":"1999","unstructured":"Giuliano F, Hultling C, El Masry WS, Smith MD, Osterloh IH, Orr M et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group. Ann Neurol 1999; 46: 15\u201321.","journal-title":"Ann Neurol"},{"key":"BFsc20163_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/10790268.2008.11753647","volume":"31","author":"S Ergin","year":"2008","unstructured":"Ergin S, Gunduz B, Ugurlu H, Sivrioglu K, Oncel S, Gok H et al. A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction. J Spinal Cord Med 2008; 31: 522\u2013531.","journal-title":"J Spinal Cord Med"},{"key":"BFsc20163_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1212\/01.wnl.0000194260.43583.32","volume":"66","author":"F Giuliano","year":"2006","unstructured":"Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE et al. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006; 66: 210\u2013216.","journal-title":"Neurology"},{"key":"BFsc20163_CR29","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1001\/archneur.64.11.nct70001","volume":"64","author":"F Giuliano","year":"2007","unstructured":"Giuliano F, Sanchez-Ramos A, Lochner-Ernst D, Del Popolo G, Cruz N, Leriche A et al. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 2007; 64: 1584\u20131592.","journal-title":"Arch Neurol"},{"key":"BFsc20163_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1179\/2045772312Y.0000000004","volume":"35","author":"N Rizio","year":"2012","unstructured":"Rizio N, Tran C, Sorenson M . Efficacy and satisfaction rates of oral PDE5is in the treatment of erectile dysfunction secondary to spinal cord injury: a review of literature. J Spinal Cord Med 2012; 35: 219\u2013228.","journal-title":"J Spinal Cord Med"},{"key":"BFsc20163_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.sc.3101198","volume":"39","author":"F Biering-Sorensen","year":"2001","unstructured":"Biering-Sorensen F, Sonksen J . Sexual function in spinal cord lesioned men. Spinal Cord 2001; 39: 455\u2013470.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR32","first-page":"628","volume":"33","author":"FJ Courtois","year":"1995","unstructured":"Courtois FJ, Charvier KF, Leriche A, Raymond DP, Eyssette M . Clinical approach to erectile dysfunction in spinal cord injured men. A review of clinical and experimental data. Paraplegia 1995; 33: 628\u2013635.","journal-title":"Paraplegia"},{"key":"BFsc20163_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11934-009-0076-x","volume":"10","author":"TA Linsenmeyer","year":"2009","unstructured":"Linsenmeyer TA . Treatment of erectile dysfunction following spinal cord injury. Curr Urol Rep 2009; 10: 478\u2013484.","journal-title":"Curr Urol Rep"},{"key":"BFsc20163_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0022-5347(17)43252-6","volume":"138","author":"AA Sidi","year":"1987","unstructured":"Sidi AA, Cameron JS, Dykstra DD, Reinberg Y, Lange PH . Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. J Urol 1987; 138: 539\u2013542.","journal-title":"J Urol"},{"key":"BFsc20163_CR35","first-page":"731","volume":"33","author":"SF Tang","year":"1995","unstructured":"Tang SF, Chu NK, Wong MK . Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report. Paraplegia 1995; 33: 731\u2013733.","journal-title":"Paraplegia"},{"key":"BFsc20163_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.sc.3100361","volume":"35","author":"R Renganathan","year":"1997","unstructured":"Renganathan R, Suranjan B, Kurien T . Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions. Spinal Cord 1997; 35: 99\u2013103.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0090-4295(98)00435-X","volume":"53","author":"DR Bodner","year":"1999","unstructured":"Bodner DR, Haas CA, Krueger B, Seftel AD . Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 1999; 53: 199\u2013202.","journal-title":"Urology"},{"key":"BFsc20163_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.sc.3101950","volume":"45","author":"JM Soler","year":"2007","unstructured":"Soler JM, Previnaire JG, Denys P, Chartier-Kastler E . Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord 2007; 45: 169\u2013173.","journal-title":"Spinal Cord"},{"key":"BFsc20163_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/10790268.2008.11753979","volume":"31","author":"A Shafik","year":"2008","unstructured":"Shafik A, Shafik AA, Shafik IA, El Sibai O . Percutaneous perineal electrostimulation induces erection: clinical significance in patients with spinal cord injury and erectile dysfunction. J Spinal Cord Med 2008; 31: 40\u201343.","journal-title":"J Spinal Cord Med"},{"key":"BFsc20163_CR40","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822\u2013830.","journal-title":"Urology"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc20163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:31:27Z","timestamp":1684621887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc20163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFsc20163"],"URL":"https:\/\/doi.org\/10.1038\/sc.2016.3","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]},"assertion":[{"value":"29 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}